A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Chronic Urinary Tract Infections (UTI)
- Conditions
- Chronic Urinary Tract InfectionChronic UTI
- Interventions
- Other: No Intervention
- Registration Number
- NCT04100980
- Lead Sponsor
- ProgenaBiome
- Brief Summary
Correlation of Microbiome to Chronic Urinary Tract Infections (UTI) via Relative Abundance Found in Microbiome Sequencing
- Detailed Description
Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized among specific Chronic UTI types.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 25
- Signed informed consent by patient
- Male or female patients age 18 and older.
- Diagnosis of chronic UTIs by a physician based upon urinalysis and/or urine culture.
- Refusal by patient to sign informed consent form
- Treatment with antibiotics within 2 weeks prior to screening
- Treatment with probiotics within 6 weeks prior to screening
- History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
- Postoperative stoma, ostomy, or ileoanal pouch
- Participation in any experimental drug protocol within the past 12 weeks
- Treatment with total parenteral nutrition
- Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
- Inability of patient to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Chronic UTI No Intervention Patients who have been diagnosed with chronic urinary tract infections (UTI).
- Primary Outcome Measures
Name Time Method Correlation of Microbiome to chronic Urinary Tract Infection (UTI) via Relative Abundance Found in Microbiome Sequencing 1 year Relative abundance of bacterial classes within taxonomic phyla and, more broadly, within their domain will be analyzed by sequencing the gut microbiome. These data will then be categorized among specific chronic urinary tract infection (UTI) types.
- Secondary Outcome Measures
Name Time Method Validation of Sequencing Methods 1 year To validate the methods used to sequence samples
Trial Locations
- Locations (1)
ProgenaBiome
🇺🇸Ventura, California, United States